Evidence map›Paper›PMID 25136124›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2014

Xylan utilization in human gut commensal bacteria is orchestrated by unique modular organization of polysaccharide-degrading enzymes.

Meiling Zhang, Jonathan R Chekan, Dylan Dodd, Pei-Ying Hong, Lauren Radlinski, Vanessa Revindran, Satish K Nair, Roderick I Mackie, Isaac Cann

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed
10.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 158 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. BoGH13ACellular and molecular life sciences : CMLS · 2023
    Article
  19. Frontiers in nutrition · 2023
    Review
  20. Article

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Meiling ZhangEnergy Biosciences Institute, Institute for Genomic Biology, and Departments of Animal Sciences.
Jonathan R ChekanBiochemistry, and.
Dylan DoddEnergy Biosciences Institute, Institute for Genomic Biology, and Microbiology, University of Illinois at Urbana-Champaign, Urbana, IL 61801.
Pei-Ying HongDepartments of Animal Sciences.
Lauren RadlinskiEnergy Biosciences Institute, Institute for Genomic Biology, and Microbiology, University of Illinois at Urbana-Champaign, Urbana, IL 61801.
Vanessa RevindranEnergy Biosciences Institute, Institute for Genomic Biology, and.
Satish K NairInstitute for Genomic Biology, and Biochemistry, and icann@illinois.edu s-nair@life.illinois.edu r-mackie@illinois.edu.
Roderick I MackieEnergy Biosciences Institute, Institute for Genomic Biology, and Departments of Animal Sciences, icann@illinois.edu s-nair@life.illinois.edu r-mackie@illinois.edu.
Isaac CannEnergy Biosciences Institute, Institute for Genomic Biology, and Departments of Animal Sciences, Microbiology, University of Illinois at Urbana-Champaign, Urbana, IL 61801 icann@illinois.edu s-nair@life.illinois.edu r-mackie@illinois.edu.
Energy Biosciences Institute · USCenter for Genomic Science · ITUniversity of Illinois Urbana-Champaign · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Enzymes that degrade dietary and host-derived glycans represent the most abundant functional activities encoded by genes unique to the human gut microbiome. However, the biochemical activities of a vast majority of the glycan-degrading enzymes are poorly understood. Here, we use transcriptome sequencing to understand the diversity of genes expressed by the human gut bacteria Bacteroides intestinalis and Bacteroides ovatus grown in monoculture with the abundant dietary polysaccharide xylan. The most highly induced carbohydrate active genes encode a unique glycoside hydrolase (GH) family 10 endoxylanase (BiXyn10A or BACINT_04215 and BACOVA_04390) that is highly conserved in the Bacteroidetes xylan utilization system. The BiXyn10A modular architecture consists of a GH10 catalytic module disrupted by a 250 amino acid sequence of unknown function. Biochemical analysis of BiXyn10A demonstrated that such insertion sequences encode a new family of carbohydrate-binding modules (CBMs) that binds to xylose-configured oligosaccharide/polysaccharide ligands, the substrate of the BiXyn10A enzymatic activity. The crystal structures of CBM1 from BiXyn10A (1.8 Å), a cocomplex of BiXyn10A CBM1 with xylohexaose (1.14 Å), and the CBM from its homolog in the Prevotella bryantii B14 Xyn10C (1.68 Å) reveal an unanticipated mode for ligand binding. A minimal enzyme mix, composed of the gene products of four of the most highly up-regulated genes during growth on wheat arabinoxylan, depolymerizes the polysaccharide into its component sugars. The combined biochemical and biophysical studies presented here provide a framework for understanding fiber metabolism by an important group within the commensal bacterial population known to influence human health.

Indexed as

BacteroidesEndo-1,4-beta XylanasesFermentationGene Expression Regulation, BacterialGene Expression Regulation, EnzymologicGlucuronatesGlycoside HydrolasesHumansIntestinesMicrobiotaMutagenesis, Site-DirectedOligosaccharidesPhylogenyPolysaccharidesSymbiosisTranscriptomeEndo-1,4-beta XylanasesGlucuronatesGlycoside HydrolaseshemicelluloseOligosaccharidesPolysaccharidesXylansxylooligosaccharidegut microbiotahemicellulosehuman nutritionRNAseqxylanolytic bacteria

Identifiers

PMID25136124
PMCPMC4156774
OpenAlexW2148604191

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.